These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 6539000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.
    Engesser L, Koopman J, de Munk G, Haverkate F, Nováková I, Verheijen JH, Briët E, Brommer EJ.
    Thromb Haemost; 1988 Aug 30; 60(1):113-20. PubMed ID: 3142089
    [Abstract] [Full Text] [Related]

  • 3. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL, Lockhart E, Warren ME, Lenkowski A, Wilhelm SE, Hoffman M.
    Biochemistry; 2006 Feb 28; 45(8):2480-7. PubMed ID: 16489740
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P, Boyer-Neumann C, Haverkate F, Grimbergen J, Larrieu MJ, Anglés-Cano E.
    Blood Coagul Fibrinolysis; 1993 Oct 28; 4(5):679-87. PubMed ID: 8292717
    [Abstract] [Full Text] [Related]

  • 8. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J, Estellés A, Vila V, Regañón E, España F, Villa P.
    Thromb Haemost; 1984 Oct 31; 52(2):196-200. PubMed ID: 6543037
    [Abstract] [Full Text] [Related]

  • 9. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F, Kani S, Hongo M, Okumura N.
    Thromb Res; 2006 Oct 31; 118(5):651-61. PubMed ID: 16412498
    [Abstract] [Full Text] [Related]

  • 10. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
    Marchi R, Lundberg U, Grimbergen J, Koopman J, Torres A, de Bosch NB, Haverkate F, Arocha Piñango CL.
    Thromb Haemost; 2000 Aug 31; 84(2):263-70. PubMed ID: 10959699
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW, Siebenlist KR, Voskuilen M, Nieuwenhuizen W.
    Thromb Haemost; 1998 Apr 31; 79(4):796-801. PubMed ID: 9569195
    [Abstract] [Full Text] [Related]

  • 12. [Place and role of tissue plasminogen activator in the fibrinolysis process].
    Wilczyńska M, Cierniewski C.
    Postepy Hig Med Dosw; 1984 Apr 31; 38(4):481-97. PubMed ID: 6399108
    [No Abstract] [Full Text] [Related]

  • 13. Concepts of clot lysis.
    Francis CW, Marder VJ.
    Annu Rev Med; 1986 Apr 31; 37():187-204. PubMed ID: 2939790
    [Abstract] [Full Text] [Related]

  • 14. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M, Baba M, Morimoto K, Nakamikawa C.
    J Clin Invest; 1983 Sep 31; 72(3):1034-41. PubMed ID: 6886002
    [Abstract] [Full Text] [Related]

  • 15. [Dysfunction of fibrinolysis as a risk factor of thrombosis].
    Kołodziejczyk J, Wachowicz B.
    Pol Merkur Lekarski; 2009 Oct 31; 27(160):341-5. PubMed ID: 19928667
    [Abstract] [Full Text] [Related]

  • 16. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH, Diamond SL.
    Thromb Haemost; 1995 Aug 31; 74(2):711-7. PubMed ID: 8585011
    [Abstract] [Full Text] [Related]

  • 17. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
    Grinenko TV, Tret'iachenko VG, Kudinov SA, Medved' LV.
    Biokhimiia; 1987 Oct 31; 52(10):1732-9. PubMed ID: 3427134
    [Abstract] [Full Text] [Related]

  • 18. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
    Stucki B, Zenhäusern R, Biedermann B, Baudo F, Redaelli R, Lämmle B, Furlan M.
    Blood Coagul Fibrinolysis; 1999 Mar 31; 10(2):93-9. PubMed ID: 10192658
    [Abstract] [Full Text] [Related]

  • 19. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K, Mimuro J, Miyata M, Sugo T, Ohmori T, Madoiwa S, Tei C, Sakata Y.
    Thromb Res; 2008 Mar 31; 121(6):773-80. PubMed ID: 17854865
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.